Home/Medicines/Deslorelin
All medicines

Deslorelin

PrescriptionCDSCO approved
GnRH agonist (gonadotropin-releasing hormone analogue)
Last reviewed 19 Apr 2026 · PetCare.AI Editorial Team
Species
Dog, Cat
Brands
2 available
Formulations
2

Mechanism of action

Continuous GnRH stimulation causes downregulation of GnRH receptors, suppressing FSH and LH release; leads to chemical castration (suppression of testosterone/estrogen)

At a glance

Class
GnRH agonist (gonadotropin-releasing hormone analogue)
Schedule
Prescription
Storage
Refrigerate at 2–8°C; do not freeze
CDSCO (India)
Vet-approved — 2008-01

Dosing

🐕

Dog

Chemical castration / Fertility suppression / Benign prostatic hyperplasia
Dose
4.7–9.4 mg implant
Route
SC implant (interscapular)
Frequency
4.7mg: every 6 months; 9.4mg: every 12 months
Max dose
9.4 mg
Duration: Reversible; fertility returns after implant wears off
🐈

Cat

Fertility suppression (off-label)
Dose
4.7 mg implant
Route
SC implant
Frequency
Every 6–18 months (variable in cats)
Max dose
4.7 mg
Duration: Duration variable; monitor for return of estrus

Formulations

💊

Subcutaneous implant — 2

Strength
4.7mg
Available in India
Strength
9.4mg

Storage

Refrigerate at 2–8°C; do not freeze

Safety

Use with caution

  • Pre-pubertal animals < 6 months
    Limited data
  • Initial flare effect
    Initial testosterone surge (2 weeks) before suppression — may temporarily worsen prostatic disease

Adverse effects

Common
Mild swelling at implant site
Initial testosterone flare (2 weeks)
Behavioral changes
Serious
Testicular atrophy (expected)
Bone marrow suppression (cats — if overly prolonged)

Monitoring parameters

Testosterone levels (4 weeks post-implant)Testicular sizeProstatic assessment (ultrasound)

Interactions

No documented interactions.

Brands

International

Suprelorin
Virbac

India

Suprelorin
Virbac India

FAQs

Frequently asked questions

What is Deslorelin?
Deslorelin is a gnrh agonist (gonadotropin-releasing hormone analogue) used in pets. Continuous GnRH stimulation causes downregulation of GnRH receptors, suppressing FSH and LH release; leads to chemical castration (suppression of testosterone/estrogen)
What is Deslorelin used for in pets?
Deslorelin is used in veterinary medicine for: Chemical castration / Fertility suppression / Benign prostatic hyperplasia; Fertility suppression (off-label).
What is the Deslorelin dose for dogs?
For dogs, Deslorelin is typically dosed as follows — Chemical castration / Fertility suppression / Benign prostatic hyperplasia: 4.7–9.4 mg implant SC implant (interscapular) 4.7mg: every 6 months; 9.4mg: every 12 months. Always consult your veterinarian for a dose tailored to your pet's weight, age, and condition.
What is the Deslorelin dose for cats?
For cats, Deslorelin is typically dosed as follows — Fertility suppression (off-label): 4.7 mg implant SC implant Every 6–18 months (variable in cats). Always consult your veterinarian for a dose tailored to your pet's weight, age, and condition.
What are the side effects of Deslorelin?
Common: Mild swelling at implant site, Initial testosterone flare (2 weeks), Behavioral changes. Serious (call your vet immediately): Testicular atrophy (expected), Bone marrow suppression (cats — if overly prolonged).
Does Deslorelin need a prescription?
Yes. Deslorelin is a prescription medication and should only be administered under veterinary supervision.

References

CDSCO approvals (India) — 1

Deslorelin Acetate 4.7 mg subcutaneous Implant for dogs.,
M/s Virbac Animal Health India pvt ltd · Approved 18.02.2022
for the induction of temporary infertility in healthy entire sexually mature male dogs.
Source: CDSCO Veterinary Drug Approval Registry (1969–2026)

References

Textbooks & handbooks

  • Plumb, D.C. Plumb's Veterinary Drug Handbook. 10th ed., Wiley-Blackwell, 2023.
  • Vail, D.M., Thamm, D.H., & Liptak, J.M. (eds.). Withrow & MacEwen's Small Animal Clinical Oncology. 6th ed., Saunders/Elsevier, 2020.
  • Riviere, J.E., & Papich, M.G. (eds.). Veterinary Pharmacology and Therapeutics. 10th ed., Wiley-Blackwell, 2018.
  • National Research Council. Nutrient Requirements of Dogs and Cats. National Academies Press, Washington DC, 2006.
  • The Merck Veterinary Manual. Merck & Co., Online edition. https://www.merckvetmanual.com/

Clinical guidelines & consensus

  • Fletcher, D.J., Boller, M., Brainard, B.M., et al. "RECOVER Evidence and Knowledge Gap Analysis on Veterinary CPR." Journal of Veterinary Emergency and Critical Care, 2012;22(S1):S102–S131.
  • American Animal Hospital Association. 2018 AAHA Diabetes Management Guidelines for Dogs and Cats. AAHA Press.

Journals & peer-reviewed studies

  • Hogan, D.F., Fox, P.R., Jacob, K., et al. "Secondary prevention of cardiogenic arterial thromboembolism in the cat: The FAT CAT study." Journal of Veterinary Cardiology, 2015;17(Suppl 1):S306–S317.
  • Boswood, A., Häggström, J., Gordon, S.G., et al. "Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study — A Randomized Clinical Trial." Journal of Veterinary Internal Medicine, 2016;30(6):1765–1779.
  • ASPCA Animal Poison Control Center. Toxicology and Poison Management Guidelines. American Society for the Prevention of Cruelty to Animals. https://www.aspca.org/pet-care/animal-poison-control

Regulatory & approvals

  • Central Drugs Standard Control Organisation (CDSCO), Government of India. Veterinary Drug Approval Registry, 1969–2026. Directorate General of Health Services. https://cdsco.gov.in/

Databases

  • Washington State University, College of Veterinary Medicine. Veterinary Clinical Pharmacology Laboratory (VCPL) — MDR1 Multidrug Sensitivity Database. https://vcpl.vetmed.wsu.edu/
Educational reference only
This information is provided for educational purposes and is not a substitute for professional veterinary advice, diagnosis, or treatment. Always consult a qualified veterinarian before administering any medication to your pet. Find a vet near you →